Six months after second dose ideal time for booster: Bharat Biotech CMD
New Delhi: Hyderabad-based pharma major Bharat Biotech founder and Managing Director Krishna Ella has said that an ideal time for ...
Read moreNew Delhi: Hyderabad-based pharma major Bharat Biotech founder and Managing Director Krishna Ella has said that an ideal time for ...
Read moreNew Delhi: Hyderabad-based pharma major Bharat Biotech's US partner Ocugen has sought the Emergency Use Authorisation (EUA) from the US ...
Read moreNew Delhi: Vaccine maker Bharat Biotech has said the Central Drugs Standard Control Organisation (CDSCO) has approved the extension of ...
Read moreUnited Nations/Geneva: The Emergency Use Listing nod to Bharat Biotech's Covaxin, which was found to have 78% efficacy against severe ...
Read moreHyderabad: India's drug regulator, the Central Drugs Standards Control Organisation (CDSCO) has approved the extension of shelf life of indigenously-developed ...
Read moreNew Delhi: After Australia recognised Bharat Biotech's Covaxin for allowing entry of travellers who had received the vaccine, five more ...
Read moreUnited Nations/Geneva: India's Bharat Biotech has been submitting data on the EUL of Covaxin “regularly and very quickly” to a ...
Read moreUnited Nations/Geneva: A technical advisory group of the World Health Organisation was Tuesday reviewing data on Covaxin for the emergency ...
Read moreNew Delhi: The World Health Organisation is likely to grant emergency use approval to Bharat Biotech's Covaxin "within 24 hours", ...
Read moreNew Delhi: An expert panel of India’s Central Drug Authority has recommended granting emergency use authorisation (EUA) to Bharat Biotech’s ...
Read more